United States - English - NLM (National Library of Medicine)

rebel distributors corp - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphenadrine citrate 50 mg - - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate, aspirin, and caffeine tablets do not directly relax tense skeletal muscles in man. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate, aspirin, and caffeine tablets do not directly relax tense skeletal muscles in man. because of the mild anti-cholinergic effect of orphenadrine, orphenadrine citrate, aspirin, and caffeine tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy, or obstructions at the bladder neck. orphenadrine citrate, aspirin, and caffeine tab

United States - English - NLM (National Library of Medicine)

atland pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphenadrine citrate, aspirin and caffeine 50 mg/ 770 mg/ 60 mg tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate, aspirin and caffeine tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphenadrine citrate, aspirin and caffeine tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphenadrine citrate, aspirin and caffeine tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contrai

United States - English - NLM (National Library of Medicine)

ina pharmaceutics, inc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphenadrine citrate, aspirin and caffeine 50 mg/ 770 mg/ 60 mg tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate, aspirin and caffeine tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphenadrine citrate, aspirin and caffeine tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphenadrine citrate, aspirin and caffeine tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contrai

United States - English - NLM (National Library of Medicine)

atland pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate, aspirin and caffeine tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphenadrine citrate, aspirin and caffeine tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphenadrine citrate, aspirin and caffeine tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

United States - English - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphengesic forte (orphenadrine citrate, aspirin and caffeine 50 mg/ 770 mg/ 60 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphengesic forte tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphengesic forte tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphengesic forte tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous h

United States - English - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphengesic forte (orphenadrine citrate, aspirin and caffeine 50 mg/ 770 mg/ 60 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphengesic forte tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphengesic forte tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphengesic forte tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous h

United States - English - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - norgesic tm (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic tm tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, norgesic tm tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. norgesic tm tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

Canada - English - Health Canada

3m pharmaceuticals, a division of 3m canada company - orphenadrine citrate; acetylsalicylic acid; caffeine - tablet - 25mg; 385mg; 30mg - orphenadrine citrate 25mg; acetylsalicylic acid 385mg; caffeine 30mg - miscellaneous skeletal muscle relaxants

Canada - English - Health Canada

3m pharmaceuticals, a division of 3m canada company - orphenadrine citrate; acetylsalicylic acid; caffeine - tablet - 50mg; 770mg; 60mg - orphenadrine citrate 50mg; acetylsalicylic acid 770mg; caffeine 60mg - miscellaneous skeletal muscle relaxants

United States - English - NLM (National Library of Medicine)

poly pharmaceuticals, inc. - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - norgesic forte 50 mg/770mg/60 mg tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic forte tablets do not directly relax tense skeletal muscles in man. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic forte tablets do not directly relax tense skeletal muscles in man. because of the mild anti-cholinergic effect of orphenadrine, norgesic forte tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy, or obstructions at the bladder neck. norgesic forte tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.